EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Elixinol Wellness's Enterprise Value is A$5.76 Mil.
Elixinol Wellness's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.78 Mil. Therefore, Elixinol Wellness's EV-to-FCF for today is -2.07.
The historical rank and industry rank for Elixinol Wellness's EV-to-FCF or its related term are showing as below:
ASX:EXL'
s EV-to-FCF Range Over the Past 10 Years
Min: -52.35 Med: -0.39 Max: 0.51
Current: -2.54
During the past 6 years, the highest EV-to-FCF of Elixinol Wellness was 0.51. The lowest was -52.35. And the median was -0.39.
ASX:EXL's EV-to-FCF is ranked worse than 100% of 524
companies
in the Drug Manufacturers industry
Industry Median: 25.63
vs ASX:EXL: -2.54
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Elixinol Wellness's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Elixinol Wellness's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elixinol Wellness's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Elixinol Wellness's EV-to-FCF falls into.
Elixinol Wellness's current Enterprise Value is A$5.76 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elixinol Wellness (ASX:EXL) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Elixinol Wellness's PE Ratio for today is calculated as:
Elixinol Wellness's share price for today is A$0.004.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elixinol Wellness's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.012.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Elixinol Wellness EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Elixinol Wellness's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:EXL has been successfully added to your 